IMCC Net Receivables from 2010 to 2026

IMCC Stock  USD 1.14  0.01  0.87%   
Im Cannabis' Net Receivables is increasing over the years with slightly volatile fluctuation. Overall, Net Receivables is expected to go to about 20.1 M this year. During the period from 2010 to 2026 Im Cannabis Net Receivables annual values regression line had geometric mean of  113,218 and mean square error of 40.8 T. View All Fundamentals
 
Net Receivables  
First Reported
2003-06-30
Previous Quarter
20.9 M
Current Value
11.3 M
Quarterly Volatility
M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Im Cannabis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Im Cannabis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Interest Expense of 5.4 M or Total Revenue of 65.2 M, as well as many indicators such as Price To Sales Ratio of 0.15, Dividend Yield of 0.0 or PTB Ratio of 1.59. IMCC financial statements analysis is a perfect complement when working with Im Cannabis Valuation or Volatility modules.
  
Build AI portfolio with IMCC Stock
Check out the analysis of Im Cannabis Correlation against competitors.
Analyzing Im Cannabis's Net Receivables over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Receivables has evolved provides context for assessing Im Cannabis's current valuation and future prospects.

Latest Im Cannabis' Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Im Cannabis Corp over the last few years. It is Im Cannabis' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Im Cannabis' overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

IMCC Net Receivables Regression Statistics

Arithmetic Mean6,873,942
Geometric Mean113,218
Coefficient Of Variation140.71
Mean Deviation7,975,187
Median16,716
Standard Deviation9,672,256
Sample Variance93.6T
Range31.2M
R-Value0.77
Mean Square Error40.8T
R-Squared0.59
Significance0.0003
Slope1,473,148
Total Sum of Squares1496.8T

IMCC Net Receivables History

202620.1 M
202519.2 M
202416.7 M
202311.3 M
202210.5 M
202131.2 M
20205.7 M

About Im Cannabis Financial Statements

Im Cannabis stakeholders use historical fundamental indicators, such as Im Cannabis' Net Receivables, to determine how well the company is positioned to perform in the future. Although Im Cannabis investors may analyze each financial statement separately, they are all interrelated. For example, changes in Im Cannabis' assets and liabilities are reflected in the revenues and expenses on Im Cannabis' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Im Cannabis Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables19.2 M20.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Im Cannabis Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Im Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Im Cannabis Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Im Cannabis Corp Stock:
Check out the analysis of Im Cannabis Correlation against competitors.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Will Biotechnology sector continue expanding? Could IMCC diversify its offerings? Factors like these will boost the valuation of Im Cannabis. Market participants price IMCC higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Im Cannabis data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.50)
Revenue Per Share
15.045
Quarterly Revenue Growth
(0)
Return On Assets
(0.07)
Return On Equity
(1.20)
Understanding Im Cannabis Corp requires distinguishing between market price and book value, where the latter reflects IMCC's accounting equity. The concept of intrinsic value - what Im Cannabis' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Im Cannabis' price substantially above or below its fundamental value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Im Cannabis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.